Eli Lilly (LLY) remains a core holding at 7% of NAV, but I have trimmed my position by 50% after a 38.8% price return since purchasing earlier in 2025. I have taken the proceeds and increased my MP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback